3-41224549-G-A
Variant names: 
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_001904.4(CTNNB1):c.37G>A(p.Ala13Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: not found (cov: 32) 
Consequence
 CTNNB1
NM_001904.4 missense
NM_001904.4 missense
Scores
 3
 5
 11
Clinical Significance
Conservation
 PhyloP100:  10.0  
Publications
23 publications found 
Genes affected
 CTNNB1  (HGNC:2514):  (catenin beta 1) The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016] 
CTNNB1 Gene-Disease associations (from GenCC):
- exudative vitreoretinopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
 - severe intellectual disability-progressive spastic diplegia syndromeInheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Illumina, G2P, Ambry Genetics
 - exudative vitreoretinopathy 7Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (MetaRNN=0.28936157). 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CTNNB1 | NM_001904.4  | c.37G>A | p.Ala13Thr | missense_variant | Exon 3 of 15 | ENST00000349496.11 | NP_001895.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| CTNNB1 | ENST00000349496.11  | c.37G>A | p.Ala13Thr | missense_variant | Exon 3 of 15 | 1 | NM_001904.4 | ENSP00000344456.5 | ||
| CTNNB1 | ENST00000645982.1  | c.37G>A | p.Ala13Thr | missense_variant | Exon 3 of 16 | ENSP00000494845.1 | ||||
| CTNNB1 | ENST00000715152.1  | n.37G>A | non_coding_transcript_exon_variant | Exon 3 of 16 | ENSP00000520353.1 | 
Frequencies
GnomAD3 genomes  Cov.: 32 
GnomAD3 genomes 
Cov.: 
32
GnomAD4 exome Cov.: 31 
GnomAD4 exome 
Cov.: 
31
GnomAD4 genome  Cov.: 32 
GnomAD4 genome 
Cov.: 
32
ClinVar
Significance: Likely pathogenic 
Submissions summary: Pathogenic:1 
Revision: no assertion criteria provided
LINK: link 
Submissions by phenotype
Melanoma    Pathogenic:1 
Jul 14, 2015
Database of Curated Mutations (DoCM)
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Benign 
 BayesDel_addAF 
 Uncertain 
D 
 BayesDel_noAF 
 Benign 
 DANN 
 Uncertain 
 DEOGEN2 
 Benign 
T;T;T;T;T;T;T;T;T;T;T;T;.;T;T;T;T;T;.;T;T;T;T;.;.;.;T;T;.;T;T;T;T;.;T;T;T;T;T;T;T 
 Eigen 
 Benign 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Pathogenic 
D 
 LIST_S2 
 Uncertain 
.;D;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;.;D;.;.;.;.;T;D;D;.;.;D;.;.;.;.;D;.;D;.;.;.;.;D 
 M_CAP 
 Benign 
T 
 MetaRNN 
 Benign 
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T 
 MetaSVM 
 Benign 
T 
 MutationAssessor 
 Benign 
N;.;N;.;N;N;N;N;N;.;N;N;.;.;N;N;N;.;.;.;.;N;N;.;.;.;N;.;.;N;N;.;N;.;N;.;N;N;N;N;N 
 PhyloP100 
 PrimateAI 
 Pathogenic 
D 
 PROVEAN 
 Benign 
.;N;.;.;N;.;D;.;N;.;N;N;.;.;N;.;.;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;N;.;.;N 
 REVEL 
 Benign 
 Sift 
 Uncertain 
.;D;.;.;T;.;.;.;T;.;T;T;.;.;T;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;T 
 Sift4G 
 Pathogenic 
.;D;.;.;T;.;.;.;T;.;T;T;.;.;T;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;T 
 Polyphen 
B;.;B;.;B;B;B;B;B;.;B;B;.;.;B;B;B;.;.;.;.;B;B;.;.;.;B;.;.;B;B;.;B;.;B;.;B;B;B;B;B 
 Vest4 
 0.60, 0.61, 0.61, 0.60 
 MutPred 
Gain of glycosylation at A13 (P = 0.0062);.;Gain of glycosylation at A13 (P = 0.0062);.;Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);.;Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);.;.;Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);.;.;.;.;Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);.;Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);.;Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);.;Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);Gain of glycosylation at A13 (P = 0.0062);
 MVP 
 0.84 
 MPC 
 1.1 
 ClinPred 
D 
 GERP RS 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.